Citations (0)
Keep up to date with the latest research on this topic with citation updates for this article.
Journal of Asthma and Allergy
Volume 16, 2023 - Issue
REVIEW
Mometasone/Indacaterol/Glycopyrronium (MF/IND/GLY) and MF/IND at Different MF Strengths versus Fluticasone Propionate/Salmeterol Xinafoate (FLU/SAL) and FLU/SAL+ Tiotropium in Patients with Asthma
Richard N van Zyl-Smit1 Division of Pulmonology and UCT Lung Institute, University of Cape Town, Cape Town, South Africa
https://orcid.org/0000-0002-4115-5362View further author information
https://orcid.org/0000-0002-4115-5362View further author information, , Huib AM Kerstjens3 Department of Pulmonology, University of Groningen, University Medical Center Groningen, and Groningen Research Institute for Asthma and COPD, Groningen, the Netherlandshttps://orcid.org/0000-0001-7705-7927View further author information
https://orcid.org/0000-0001-7705-7927View further author information, , Hironori Sagara5 Department of Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, Japanhttps://orcid.org/0000-0003-2376-1606View further author information
https://orcid.org/0000-0003-2376-1606View further author information, Ana-Maria Tanase6 Novartis Pharma AG, Basel, SwitzerlandCorrespondence[email protected]
https://orcid.org/0000-0003-4987-9434View further author information
https://orcid.org/0000-0003-4987-9434View further author information, , , , & show all